S-Adenosylhomocysteine, a potent intracellular methylation inhibitor, is su
ggested as a potential mediator for hyperhomocysteinemia-related vascular c
hanges. We investigated the effect of acute and chronic hyperhomocysteinemi
a on intracellular S-adenosylhomocysteine and S-adenosylmethionine in rats
and humans. Elevated plasma homocysteine in rats infused with homocysteine
produced an increase in S-adenosylhomocysteine (P < 0.001) but not S-adenos
ylmethionine levels (P > 0.05) in various rat tissues. However intraerythro
cyte S-adenosylhomocysteine and S-adenosylmethionine levels were not change
d in homocysteine-infused rats and human subjects with experimentally acute
hyperhomocysteinemia by methionine loading test. In contrast, erythrocyte
S-adenosylhomocysteine levels were significantly higher in chronic renal fa
ilure patients, who had chronically elevated plasma homocysteine levels, th
an in either vascular disease patients or healthy controls (P < 0.05). In c
onclusion, acute hyperhomocysteinemia can increase intracellular S-adenosyl
homocysteine levels in tissues actively involved in homocysteine metabolism
. The findings are relevant to homocysteine-related endothelial dysfunction
since S-adenosylhomocysteine modulates endothelial cell apoptosis. (C) 200
0 Academic Press.